Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.

Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.

Pothoven KL, Kheradmand T, Yang Q, Houlihan JL, Zhang H, Degutes M, Miller SD, Luo X.

Am J Transplant. 2010 Aug;10(8):1774-84. doi: 10.1111/j.1600-6143.2010.03199.x.

2.

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.

Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM, Suthanthiran M.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2821-6.

3.

Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.

Yang H, Cheng EY, Sharma VK, Lagman M, Chang C, Song P, Ding R, Muthukumar T, Suthanthiran M.

Transplantation. 2012 Mar 27;93(6):580-8. doi: 10.1097/TP.0b013e318244dd67.

4.

In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.

Guo X, Jie Y, Ren D, Zeng H, Zhang Y, He Y, Pan Z.

Hum Immunol. 2012 Nov;73(11):1061-7. doi: 10.1016/j.humimm.2012.08.014.

PMID:
22939904
5.

Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Wang X, Wang W, Xu J, Hong J, Le Q.

Exp Clin Transplant. 2013 Feb;11(1):56-62. doi: 10.6002/ect.2012.0025.

6.

Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.

Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N.

Br J Dermatol. 2008 Jun;158(6):1197-209. doi: 10.1111/j.1365-2133.2008.08555.x.

PMID:
18410422
7.

Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.

Wang X, Wang W, Xu J, Le Q.

Transplant Proc. 2013 Mar;45(2):528-37. doi: 10.1016/j.transproceed.2012.06.064.

PMID:
23267787
8.
9.

Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.

Wang GY, Zhang Q, Yang Y, Chen WJ, Liu W, Jiang N, Chen GH.

Hepatobiliary Pancreat Dis Int. 2012 Apr;11(2):203-8.

10.

Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.

Yoon IH, Choi SE, Kim YH, Yang SH, Park JH, Park CS, Kim Y, Kim JS, Kim SJ, Simpson E, Park CG.

Transplantation. 2008 Nov 27;86(10):1352-60. doi: 10.1097/TP.0b013e31818aa43c. Erratum in: Transplantation. 2009 Jan 15;87(1):155.

PMID:
19034003
11.

Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.

Xia G, He J, Leventhal JR.

Am J Transplant. 2008 Feb;8(2):298-306. doi: 10.1111/j.1600-6143.2007.02088.x.

12.

PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice.

Liu H, Bakthavatsalam R, Meng Z, Li Z, Li W, Perkins JD, Reyes J.

Transplant Proc. 2013 Jun;45(5):1853-5. doi: 10.1016/j.transproceed.2013.03.015.

PMID:
23769057
13.
14.

Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.

Huang H, Dawicki W, Zhang X, Town J, Gordon JR.

J Immunol. 2010 Nov 1;185(9):5003-10. doi: 10.4049/jimmunol.0903446.

15.

Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.

He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.

Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016.

PMID:
19486771
16.
17.
18.

Dendritic cells and B cells cooperate in the generation of CD4(+)CD25(+)FOXP3(+) allogeneic T cells.

Moore C, Sauma D, Reyes PA, Morales J, Rosemblatt M, Bono MR, Fierro JA.

Transplant Proc. 2010 Jan-Feb;42(1):371-5. doi: 10.1016/j.transproceed.2009.12.044.

PMID:
20172352
19.

Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.

Prochazkova J, Fric J, Pokorna K, Neuwirth A, Krulova M, Zajicova A, Holan V.

Immunology. 2009 Sep;128(1 Suppl):e670-8. doi: 10.1111/j.1365-2567.2009.03060.x.

20.

Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment.

Schliesser U, Chopra M, Beilhack A, Appelt C, Vogel S, Schumann J, Panov I, Vogt K, Schlickeiser S, Olek S, Wood K, Brandt C, Volk HD, Sawitzki B.

Eur J Immunol. 2013 Dec;43(12):3291-305. doi: 10.1002/eji.201243292.

Items per page

Supplemental Content

Support Center